Fox Chase cancer genetics specialist receives inaugural BRCA Impact Award
Click Here to Manage Email Alerts
Mary B. Daly, MD, PhD, FACP, has been named the inaugural recipient of the BRCA Impact Award, presented by Penn Medicine’s Basser Center for BRCA.
The award recognizes a national leader in the field of cancer genetics.
Daly is professor in the department of clinical genetics and Timothy R. Talbot Jr. chair in cancer research at Fox Chase Cancer Center.
In addition to her research in clinical cancer genetics, she has designed educational programs to help both high-risk individuals and their health care providers.
In 1991, she founded a risk assessment program at Fox Chase that focused on assessing individuals’ risk for breast cancer or ovarian cancer. The program — which also provides counseling, genetic testing and screening — now includes several other malignancies, including melanoma and lung, prostate, kidney and gastrointestinal cancers.
“When you go to work every day, you don’t think you’re making an impact, you just think you’re doing your job and taking care of patients,” Daly said in a press release. “[This award] made me realize — looking back over all the years that I’ve been here — that I have made an impact in terms of setting up one of the first risk-assessment programs for cancer prevention, even before we knew about the cancer genes.”
The Basser Center for BRCA strives to accelerate BRCA-related cancer research and the development of targeted therapies.
“With the inaugural BRCA Impact Award, we’re excited to honor a cancer genetics leader here in Philadelphia, the distinguished Mary Daly, whose work has impacted so many in our region and beyond,” Susan M. Domchek, MD, the center’s director, said in the release.
Read more about
Click Here to Manage Email Alerts